| Microvascular complications of type 2 diabetes mellitus C Faselis, A Katsimardou, K Imprialos, P Deligkaris, M Kallistratos, ... Current vascular pharmacology 18 (2), 117-124, 2020 | 457 | 2020 |
| Diabetes and lipid metabolism VG Athyros, M Doumas, KP Imprialos, K Stavropoulos, E Georgianou, ... Hormones 17 (1), 61-67, 2018 | 291 | 2018 |
| Hypertension in metabolic syndrome: novel insights A Katsimardou, K Imprialos, K Stavropoulos, A Sachinidis, M Doumas, ... Current Hypertension Reviews 16 (1), 12-18, 2020 | 98 | 2020 |
| Renin-angiotensin system inhibitors and COVID-19: a systematic review and meta-analysis. Evidence for significant geographical disparities D Patoulias, A Katsimardou, K Stavropoulos, K Imprialos, MS Kalogirou, ... Current hypertension reports 22 (11), 1-13, 2020 | 47 | 2020 |
| Dysmetabolic iron overload in metabolic syndrome A Sachinidis, M Doumas, K Imprialos, K Stavropoulos, A Katsimardou, ... Current pharmaceutical design 26 (10), 1019-1024, 2020 | 47 | 2020 |
| COVID19 and increased mortality in African Americans: socioeconomic differences or does the renin angiotensin system also contribute? M Doumas, D Patoulias, A Katsimardou, K Stavropoulos, K Imprialos, ... Journal of human hypertension 34 (11), 764-767, 2020 | 43 | 2020 |
| Renovascular hypertension: novel insights C Boutari, E Georgianou, A Sachinidis, A Katsimardou, K Christou, ... Current Hypertension Reviews 16 (1), 24-29, 2020 | 34 | 2020 |
| Cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of cardiovascular outcome trials DI Patoulias, A Boulmpou, E Teperikidis, A Katsimardou, F Siskos, ... World Journal of Cardiology 13 (10), 585, 2021 | 31 | 2021 |
| Efficacy and safety of renal denervation for the management of arterial hypertension: a systematic review and meta‐analysis of randomized, sham‐controlled, catheter‐based trials K Stavropoulos, D Patoulias, K Imprialos, M Doumas, A Katsimardou, ... The Journal of Clinical Hypertension 22 (4), 572-584, 2020 | 29 | 2020 |
| Female sexual dysfunction: a problem hidden in the shadows KP Imprialos, K Koutsampasopoulos, A Katsimardou, S Bouloukou, ... Current pharmaceutical design 27 (36), 3762-3774, 2021 | 22 | 2021 |
| Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter … D Patoulias, K Stavropoulos, K Imprialos, A Katsimardou, MS Kalogirou, ... Diabetes Research and Clinical Practice 158, 107927, 2019 | 17 | 2019 |
| Treatment strategies for hypertension in patients with type 1 diabetes A Katsimardou, K Imprialos, K Stavropoulos, A Sachinidis, M Doumas, ... Expert Opinion on Pharmacotherapy 21 (10), 1241-1252, 2020 | 14 | 2020 |
| Glucagon-like peptide-1 receptor agonists or sodium–glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta … D Patoulias, A Katsimardou, MS Kalogirou, I Zografou, M Toumpourleka, ... Diabetes & metabolism 46 (4), 272-279, 2020 | 12 | 2020 |
| Risk Scores and Prediction Models in Chronic Heart Failure: A Comprehensive Review M Toumpourleka, D Patoulias, A Katsimardou, M Doumas, ... Current Pharmaceutical Design 27 (10), 1289-1297, 2021 | 9 | 2021 |
| Sodium–glucose cotransporter 2 inhibitors and major COVID-19 outcomes: promising mechanisms, conflicting data, and intriguing clinical decisions D Patoulias, C Papadopoulos, A Katsimardou, M Toumpourleka, ... Diabetes Therapy 11 (12), 3003-3005, 2020 | 9 | 2020 |
| Right ventricular function and sexual function: exploring shadows in male and female patients with heart failure K Koutsampasopoulos, I Vogiatzis, A Ziakas, C Papadopoulos, ... The Journal of Sexual Medicine 16 (8), 1199-1211, 2019 | 8 | 2019 |
| New horizons in the pathogenesis, pathophysiology and treatment of familial hypercholesterolaemia M Viigimaa, S Heinsar, D Lovic, A Katsimardou, A Piperidou, D Duishvili Current Pharmaceutical Design 24 (31), 3599-3604, 2018 | 8 | 2018 |
| Mineralocorticoid receptor antagonists in essential and resistant hypertension KP Imprialos, S Bouloukou, G Kerpiniotis, A Katsimardou, D Patoulias, ... Current pharmaceutical design 24 (46), 5500-5507, 2018 | 7 | 2018 |
| Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective … D Patoulias, C Papadopoulos, I Zografou, A Katsimardou, A Karagiannis, ... Medicina 58 (9), 1167, 2022 | 5 | 2022 |
| Impact of primary aldosteronism in resistant hypertension K Stavropoulos, KP Imprialos, D Patoulias, A Katsimardou, M Doumas Current Hypertension Reports 24 (8), 285-294, 2022 | 5 | 2022 |
